In this review article, we introduced the importance of "motion management" in advanced particle therapy. Several publications have reported that organ motion causes dose distribution disturbances due to interplay and blurring effects. Furthermore, motion can result in target dose miss and unwanted dose to healthy structures around the target. To avoid these problems, motion should be assessed and monitored prior and during treatment. In this review article, we give an overview about clinically available motion monitoring systems. Based on the acquired motion information an adequate motion mitigation technique should be chosen. This article reviews the clinical status of motion mitigation techniques like rescanning, gating and tracking. A limited number of centers have now started the treatment of targets in the thorax and abdomen using scanned particle beams. Therefore, the establishment of guidelines for motion monitoring and motion mitigation will be essential in the coming years.
INTRODUCTION
Many tumor sites in the thorax and abdomen are subject to motion. Motion has a significant influence on the treatment quality in particle radiotherapy. From a geometrical point of view, target motion results in blurring of the dose gradients and might lead to turn on the treatment beam when the tumor is beyond the beam field. In addition to these geometrical effects, the motion of organs in the target area and within the beam's path can change the radiological path length and thus the distribution of the deposited dose. For beam scanning, there are two additional interference sources: one is due to inter-field motion in intensity-modulated particle therapy (IMPT), and the other due to interference between scanning motion and intra-fractional (or intra-field) motion which is often called interplay and typically results into under-dosage and over-dosage within the target volume. Special protocols for motion monitoring and motion mitigation during treatment delivery are necessary to guarantee target dose coverage and compliance of dose constraints for close-by critical structures. In this review, we give a summary of available motion monitoring solutions for particle radiotherapy and describe motion mitigation techniques to be used during particle therapy delivery.
MOTION MONITORING IMAGE GUIDED PARTICLE THERAPY

2.A. External surrogate motion tracking
For the thorax and abdominal regions, respiratory-correlated imaging (e.g., 4D computed tomography (CT)) or irradiation (respiratory-gated treatment) can be performed by monitoring patient respiration. External tracking systems are commercially available and are now widely used in particle beam and photon beam therapy.
There are two types of external tracking systems. The first uses tagging points with artificial markers placed on the patient abdomen and captures motion using infrared cameras; an example is the real-time position management system from infrared cameras (Varian, CA, USA), belt (Anzai, Japan), gauge (Abches, Japan) or spirometer (SDX, France). This type of system observes respiratory motion at a single point or a single information, and accordingly requires that the artificial markers be positioned to ensure a good relationship between the marker and tumor motion. 1 The second type of external tracking is monitoring of patient surface information by camera (VisionRT, England and CRAD, Sweden). For surface imaging no artificial markers are required and motion information over a whole area is obtained. The respiratory monitoring position can be the same during treatment delivery as used during planning CT acquisition. Moreover, the fixed camera provides surface motion displacement as absolute values, and the gating threshold can therefore be set at the same absolute position in every treatment fraction. Also gauge sensors monitor directly the patient surface but only at specific points and can be used to image patients in free breathing. Bengua et al., however, show that a reduction in the respiratory motion range was not possible in all cases. 2 Spirometers provide active respiratory control as well as respiratory monitoring, 3, 4 by monitoring or controlling the amount of air inhaled.
Compared to the internal tracking systems described in the next section (x-ray exposure and implanted fiducial markers), these external tracking systems are non-invasive and can be easily implemented in clinical practice. However, they rely on the assumption that the observed external respiratory signal is well correlated with the actual internal tumor motion, which is not always the case. [5] [6] [7] As external tracking does not directly capture tumor motion, and because non-rigid deformations in patient geometry can occur, not all patients show a good correlation between skin surface and internal tumor motion. Also, the tumor position is not always the same for consecutive equal respiratory phases (Fig. 1) . 8, 9 This is a clear limitation of external tracking surrogates, and a solution for this problem is not in sight. Medical staff should pay particular attention to minimizing these problems and eliminating the possibility of target dose errors 10 (Fig. 2) ; examples for this include checking the positional correlation between the skin surface and internal tumor position across exhalations by image guidance before irradiation [11] [12] [13] [14] and/or adding an extra margin during treatment planning.
2.B. Internal tumor tracking
Movement of the internal organs often includes not only respiratory motion, with a repeating cycle of a few seconds, but also higher-frequency cardiac motion and peristaltic motion with a cycle of a several tens of seconds. It is well known that the respiratory pattern shows variations (e.g., phase shift/drift/amplitude/period). To track tumor position accurately real-time, internal respiratory monitoring is required. Here, we introduce two types of tracking methods -fiducial marker tracking and markerless tracking, especially with fluoroscopic imaging -and summarize their characteristics. 
2.B.1. Fiducial marker tracking
The fiducial marker tracking method was developed and implemented first into photon beam treatment systems and later also for particle beam treatments. In the late 1990s, Hokkaido University collaborated with Mitsubishi Electronic and first developed an internal fiducial marker tracking system using real-time fluoroscopic imaging. 15 The tracking system consists of an irradiation system (linear accelerator (linac) or particle beam port) and more than two fluoroscopic imaging devices. The fiducial markers are inserted near to or in the tumor and are visible on the X-ray images, and 3D coordinates of the markers are derived from the images based on the triangulation method. When the 3D coordinates of a marker are within the gating window, the treatment beam is turned on. By doing this, gated irradiation of mobile targets is possible despite irregular respiratory motion. There are two types of the fiducial marker tracking methods.
The first method is a correlation model, which relates external surrogate motion (e.g., infrared marker used in a few commercially available systems (CyberKnife â Robotic Radiosurgery System, Accuray, Inc., 16 Sunnyvale CA, USA; Vero4DRT, 17, 18 Mitsubishi Heavy Industries Ltd., Tokyo, Japan) with the internal marker motion obtained with fluoroscopy, is generated before the treatment. During treatment, the tumor is tracked by moving the linac using a robotic manipulator or by steering the gimbals the linac is mounted on according to the external surrogate signal. A prediction technique is applied to compensate for system latency, which includes data processing, communication, position adjustment of the linac, and beam control. The correlation model error is checked by acquiring additional fluoroscopic images during treatment. If the correlation model error is larger than a preset threshold, the correlation model is rebuilt.
The second method is to turn the treatment beam on/off directly using marker positional information (SyncTraX â , Shimadzu, Kyoto, Japan, Probeat â , Hitachi, Tokyo, Japan, Toshiba, Kawasaki, Japan). Berbeco et al. have performed a conceptual study of different types of fluoroscopy-based tracking systems 19 and have shown the feasibility of linac gantry-mounted X-ray systems. Li et al. have proposed a monoscopic X-ray imaging technique based on a Bayesian approach for real-time imaging during treatment delivery. 20 In a monoscopic design, the fluoroscopic imaging dose is significantly minimized. 21 Some other studies have found ways to optimize the X-ray imaging technique 22, 23 and to improve the accuracy of fiducial marker recognition by image processing. 24 Additionally an electromagnetic transponder system was developed (Calypso â , Varian Medical Systems, Palo Alto CA, USA) that detects fiducial marker position in real time without X-rays.
While one of the major uncertainties in the fiducial marker tracking is that the implanted fiducial marker position might not provide the tumor position when the marker is not implanted in the tumor. For lung cases, the amplitude of lung tumor motion is greatest in the craniocaudal direction and is larger in the lower and peripheral lung areas, although this pattern can be considerably altered in diseased lungs. 25, 26 In one study, the average fiducial marker displacement was >10 mm in approximately 33% of lung cancers (Fig. 3) . 27 It should be noted that lung tumors are subject to baseline-shift/ drift, with "drift" representing continuous gradual changes in average tumor position, and "shift" representing noncontinuous changes (Fig. 4) . For lung treatment, the incidence of a baseline-shift/drift >3.0 mm was 6.0%, 15.5%, 14.0%, and 42.1% at 10 min after the start of irradiation for the LR, CC, and AP directions and Euclidian distance respectively. 28 Prostate motion is mainly caused by rectal gas, and displacement during 10 min was significantly larger than that during the initial 2 min (Fig. 5) . 29 Patient setup in photon beam therapy is generally performed by registration of target position or fiducial markers rather than of bony structures. This is also suitable for particle therapy. However extra care has to be taken, because particle beams are strongly affected by tissue density variations along a given path. This is especially critical in prostate treatment, where a high-density object such as the femur can be misplaced. In particle therapy, if the patient setup is performed only by registration of the target position or the fiducial markers, the particle beam may not stop at the desired position. Since the internal organs are subject to these complex motions, real-time monitoring of internal organ motion during treatment is highly recommended The incidence of adjustment is stratified in 2-minute intervals after the initial setup. The figure shows the cumulative incidence of displacement at 2, 4, 6, 8, and 10 min, and thereafter. With permission. 29 for treating mobile targets. Based on the clinical experiences in photon beam therapy, the fiducial marker tracking technique has now been integrated into a proton scanning treatment system. 30 Fiducial marker tracking still presents several challenges. Although it potentially directly detects the moving target position, the markers are subject to positional changes over the course of therapy as the tumor can changes in size and shape (>2 mm 95% confidence interval over a few weeks). 31, 32 Secondly, not all patients or all tumors can be subjected to fiducial marker implantation. Another drawback of internal tracking with fiducial markers is dose degradation (shadowing effect). When a particle beam passes through a high-density fiducial marker, the dose distribution downstream from the marker is degraded. [32] [33] [34] Opposing field angles would mitigate this effect but are not ideal for critical organ sparing. Also applying multiple fields attenuates these dose degradations effects 34 ( Fig. 6 ), but generally the number of fields in particle beam therapy is smaller than that in photon beam therapy. Third, the fiducial marker-tracking technique detects marker position using image contrast information between the marker and background. Therefore, when a marker overlaps with a high-contrast object such as bone, treatment couch, and/or immobilization devices, calculation errors can occur (Fig. 7) . To solve this problem, the medical staff has to select the fiducial marker(s) position(s) and/or uses the paired fluoroscopic imaging system to enable accurate tracking calculations before treatment.
2.B.2. Markerless tracking
The particular challenge of image-guided particle therapy (IGPT) 35 is real-time tumor tracking without fiducial markers (markerless tracking). This technique is difficult to incorporate in clinical practice. One question is how to detect 3D tumor position from digital fluoroscopy, which converts images into a two-dimensional array of pixel values. One proposed solution is to integrate computer-aided diagnosis (CAD) techniques into particle therapy, but it is difficult to perform the necessary real-time calculations for the required accuracy. While the diagnostic image cannot provide any information about the actual geometry during treatment delivery, the online image lacks prior information such as the tumor contour, OAR contours etc. Thanks to computer vision and machine learning approaches, state-of-the-art image guidance is capable of object/feature detection and recognition from medical images. These approaches provide important information to increase treatment accuracy. Instead of focusing solely on better markerless tracking algorithms using conventional image guidance, a more promising approach is to develop algorithms based on training data (prior information about a patient) built up over time. "Supervised learning IGPT" combines IGPT and machine learning. Several publications have reported on markerless tumor tracking techniques using kernel-based algorithms, 36 regression analysis, [37] [38] [39] and the multiple-template-matching technique. 40 Intrafractional bony structure motion, especially that of ribs, can pose a problem in markerless tumor tracking in the thorax, but may be dealt with by dual-energy subtraction. 41, 42 A Japanese group has successfully started respiratory gated carbon-ion scanning beam treatment using markerless tracking, 43 and has shown good positional accuracy with this technique. Further efforts to apply markerless tracking to other targets, such as pancreatic lesions, are expected. A markerless tracking system is already commercially available for photon beam therapy (CyberKnife â ; Accuray, Inc.; Sunnyvale CA, USA) and particle beam therapy (Toshiba, Tokyo, Japan). Fiduciary marker tracking and markerless tracking have advantages and disadvantages, summarized in Table I . It is up to the medical staff to select a tracking technique in accordance with patient condition and treatment strategy.
2.C. Ultrasound
Ultrasound (US) imaging is cost-effective in providing excellent contrast at high resolution for depicting soft tissue targets apart from those shielded by the lungs or cranium. As a result, it is increasingly used in radiotherapy setup verification for the measurement of inter-fraction motion. 44 The combination of rapid imaging and zero ionizing radiation dose makes US also highly suitable for estimating intra-fraction motion. However, due to the characteristics of US imaging not all locations in the thorax can be accessed. An overview about intrafraction motion management with US image guidance in external beam radiotherapy is given in a review by O'Shea et al. 45 There, the basic technology for US motion estimation, and its current clinical application is described, along with recent developments in robust motionestimation algorithms, and 3D imaging. A handful of in vivo studies have shown the feasibility of 2D US-based motion tracking of the diaphragm, 46 liver, [47] [48] [49] [50] prostate 47, 51 and lung surface. 47 Exemplary diaphragm, liver, prostate, and lung surface US images can be seen in Fig. 8 . Figure 9 shows exemplary motion signals extracted from US data for two landmark positions in the liver. 48 Liver motion estimation in 3D was demonstrated by Harris et al. 52 US has not been used for intrafraction motion estimation for lung tumors, probably due to the high attenuation of US in lung and the success of optical monitoring for surface tumors. US monitoring of diaphragm motion could, however, be combined with surface motion to obtain a better estimate of lung tumor motion.
Of the US intra-fraction motion estimation studies that employed in vivo data, comparison with the true motion (and therefore motion estimation accuracy) has either not been fully considered or has been based on manual annotations of features in B-mode images. 53 There remains a need for full in vivo investigation of the accuracy and limitations of USbased methods, and therefore a need for improved methods for measuring the true motion.
Relative to X-ray based techniques, the use of US for intra-fraction motion management is at an early stage. In particle therapy the feasibility of ultrasound based beam tracking has been reported by Prall et al. 54 They showed that delay compensation is possible via neural networks and present experimental data indicating the feasibility of ultrasound based compensation without tracking parameters from treatment planning. A challenge for particle therapy is the placement of the US transducer. Intra-fraction motion estimation requires the US transducer to remain in contact with the patient throughout treatment. This presents a challenge: finding the transducer placement allowing adequate imaging quality without impacting negatively on the RT workflow.
2.D. Magnetic resonance imaging
Whilst commonly used 4D imaging methods (4DCT and 4DCBCT) provide motion information about one averaged breathing cycle, 4DMR imaging allows studying irregularities in organ motion during free breathing over 10 min. Currently achieved temporal resolutions are in the order of 2 to 3 s. Von Siebenthal et al. developed a method that does not assume a constant breathing amplitude or strict periodicity and does not depend on an external respiratory signal. 55 Time-resolved 3D image sequences were reconstructed by retrospective stacking of dynamic 2D images using internal image-based sorting. The method was demonstrated for the liver and for the lung target areas. More recent work has been done by Paganelli et al. on retrospectively reconstructing 4D-MRI datasets from multislice acquisitions 56 and by Bernatowicz et al. on MRI-based 4D-CT generation. 57 Further developments are needed to obtain real time 4D data acquisition. In recent years, with the development of combined MRlinac machines, 58 there has been a trend toward Magnetic Resonance imaging (MRI) guided radiotherapy. It is believed that online MRI can provide a feedback loop to enable gating and beam tracking in clinical routine. [59] [60] [61] Crijns et al. established an infrastructure to realize gated radiation delivery based on MR feedback and demonstrated its potential as a first step toward more advanced image guidance techniques. 62 Since in a combined MR-linac system 4D information of a 3D part of the patient geometry is provided online, these hybrid machines are especially suited to perform motion tracking. A tracked radiation delivery is otherwise mainly restricted to the use of motion surrogate information and can therefore not deal with target deformations or adaptations for OAR positions. 2D motion information from surrogates is also not sufficient to perform tracking with particle beams. As a particle dose spot is sensitive to lateral geometry changes and density changes in beam direction, motion information in 3D is required for tracking. MRI could provide noninvasive 4D information with superior soft tissue contrast, ideal to steer the beam delivery according to the present motion. Paganelli imaging-guided versus surrogate-based motion tracking in liver radiation therapy. 63 In Fig. 10 an example of motion tracking based on MR data from this publication is shown. Cervio et al. evaluated the performance of lung tumor tracking algorithms in cine-MRI sagittal images. 64 Crijns et al. provided a proof of concept of MRI-guided tracked radiation delivery for a phantom moving in 1D. 65 Yun et al. demonstrated the use of multileaf collimator (MLC) in a MR-linac system for 2D motion tracking. 66 Theoretically the combination of particle therapy delivery and simultaneous MR imaging is also thinkable. 67 Such a proton-MR hybrid machine would combine the most precise form of radiotherapy with the most advanced 4D imaging technology. There have been initial studies on the effect of the magnetic field on particle beams performed, [68] [69] [70] which show that the impact of the magnetic field is small, and the resulting dose distributions are equivalent for 0 T and 1.5 T. Oborn et al. highlights that a lot of developments toward online guided radiotherapy have been done for combined MR-Linacs and thus a swift transition to proton therapy seems reasonable. 71 However, the real clinical benefit of online MR data for particle radiotherapy remains to be shown.
MOTION MITIGATION
Geometrical change in organs is the major cause for the degradation of dose conformation in particle beam therapy. There are two types of geometrical changes, intrafractional and interfractional. Interfractional changes include weight gain, target shrinkage, and target/organ positional reproducibility as response to the treatment. Intrafractional changes can be observed throughout the thorax and abdominal regions, and include respiration and cardiac motion which are unavoidable in treatments in the thorax and abdomen. Nowadays, the effects of intra-fractional changes for actual patient geometries have been shown in several studies. [72] [73] [74] They conclude that especially for small fraction numbers (i.e., hypo-fractionation), beam arrangements perpendicular to the main motion direction, small spot sizes and motion amplitudes above 5 mm treatment of moving targets with scanned particle beams requires motion mitigation strategies such as rescanning, gating, or tracking. For robustly optimized treatment plans, however, setup and range uncertainties, breathing motion, and interplay effects have limited impact on target coverage, dose homogeneity, and organ-atrisk dose parameters. 75 Thus, robustly optimized treatment plans might be a clinical solution to treat during free breathing if the breathing amplitude is limited and stable. An active and straight forward approaches toward the reduction in tumor motion is breath-hold. Breathing can also be stopped intentionally for several seconds, although not all patients are capable of holding their breath during treatment. An in-depth discussion of the rationale and technical implementation of Deep Inspiration Breath Hold-Based (DIBH) photon and proton treatments of upper abdominal tumors was published by Boda-Heggemann et al. 76 To solve the motion problem, "gating" and "rescanning" techniques were introduced. "Scanned beam tracking" still has many problems to solve before being implemented for clinical use. In Section 3.A., we will further elaborate the motion mitigation techniques gating and rescanning. In Section 3.B. we will comment on the motion mitigation technique tracking.
3.A. Gating and rescanning
3.A.1. Gating
First introduced into proton beam therapy at Tsukuba University in the late 1980s, 77 the respiratory gating technique is now widely used in both particle beam and photon beam therapy. Respiratory gating involves the synchronization of treatment beam irradiation or imaging with a gating signal, which is typically obtained by an external or internal tracking system as described above. The basic concept of respiratory gating is that the treatment beam is switched on only during specific respiratory phases. The timing of respiratory gating is generally selected as an approximately 30% peri-exhalation duty cycle (delivery efficiency, or the ratio of beam-on time to delivery time). This is because the human respiratory cycle is not strictly regular but varies in both amplitude and period from one cycle to the next, with exhalation accounting for greater time than inhalation, and showing better respiratory pattern reproducibility. [78] [79] [80] [81] [82] Respiratory gating primarily offers two clinical advantages, namely clinically acceptable levels of dose conformation and sparing of OARs. It does this by minimizing the magnitude of intrafractional organ motion and beam field size, respectively.
Regarding the first advantage, passively scattered beams provide a broadened field in both the lateral and depth directions to cover intrafractional tumor displacement. The resulting accumulated dose distribution to the moving target is degraded due to a blurring effect. In contrast, while pencil beam scanning to a moving target also causes a blurring effect, there is a more severe effect which results from the interplay between intrafractional tumor/organ motion and the timeline of beam spot position (called the "interplay effect"). The magnitude of the interplay effect increases with increasing tumor/organ motion displacement. The first choice in minimizing the interplay effect is to minimize the major cause of dose degradation by applying "gating." In Fig. 11 it can be seen that while an ungated scanning beam did not provide sufficient dose within a moving target, a gated proton scanning beam achieved a dose close to the distribution to the static target. The gating technique is a direct approach to the fundamental problem of dose degradation due to motion and it is less dependent on the specifications of the irradiation machine than the rescanning technique, described below.
The second clinical advantage occurs due to the possibility of reducing internal margins when employing gating. This prevents excessive dose to normal tissues by minimizing the beam field size. The example in Fig. 12 shows the successful minimization of excessive dose to the duodenum in pancreatic treatment by gating.
The gating technique faces several technical challenges. [83] [84] [85] First, the minimization of time latency is crucial to the success of gating (Fig. 13) . Time latency at the beginning of the gating window is like a delayed irradiation, and latency at the end of the gating window might result in irradiation while the target already moved out of the beam. The result will be underdosage and overdosage of nearby tissue. A second challenge is a beam request according to the gating signal while the accelerator extracted pulse timing is not ready. To overcome this, the extended flattop operation was developed with a synchrotron-based accelerator using a slowextraction method. 86 A further problem is the fact that respiratory gating prolongs the treatment time: a 30% duty cycle results in a duty cycle that is approximately 70% shorter with gating than without it. A longer treatment time over several minutes is not comfortable for the patients and can result in respiratory pattern variation, such as drift motion. Finally the assumption that external motion is well correlated with the actual internal tumor motion is questionable. The correlation between internal and external motion is also a specific challenge for tracking and will be discussed in 3.A.3.
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Most respiratory techniques define the gating window by choosing a percentage level of respiratory amplitude ("phasebased gating'). Due to interfractional positional variation, however, tumor/organ position is not always the same position in the same respiratory phase. Thus, phase-based gating involves the risk of systematically missing the target, especially for a small gating window. Alternatively, the target is only irradiated within a specific position defined during treatment planning ("amplitude-based gating"). 43, 87 This can be achieved using an internal tracking technique such as fluoroscopic imaging which provides internal motion information. However, this approach relies on markers for some tumor locations and has the disadvantaged of a relatively high imaging dose. As an example, Fig. 14 shows a case in which the   FIG. 11 . Static proton dose distribution was successfully given to the CTV (white contour). Accumulated dose distribution with 1 scan showed degraded dose conformation to the CTV under ungated treatment. However, the respiratory gating technique prevented dose degradation even with a single scan. Reproduced from reference. 110 CTV position at exhale was inside the irradiation region in the 1st fraction, but due to interfractional change moved out of the irradiation region in the exhale phase in the 12th fraction. The correct irradiation of the CTV would require the treatment beam to be "on" from end-expiration to inspiration.
In current clinical treatment protocol using phase-based gating, the treatment beam might irradiate the moving target beyond the beam field, because the target position might not be the same even though the respiratory phase is the same. In clinical protocols, oncologists have historically adjusted (generally increased) the prescribed dose as a response to low tumor control rates. This approach leads to good tumor control rates (e.g., 110% of the prescribed dose was irradiated but 100% of the prescribed dose was delivered to the target in the actual situation). However, it comes at the cost of excessive dose to normal tissues. An accurate gating alternative is amplitude-based gating. It promises to provide the correct treatment dose to a moving target and a good tumor control ratio can be achieved with less prescribed dose, minimizing also toxicity to normal tissue. This might be useful in doseescalation studies.
3.A.2. Rescanning
An approach to especially minimize the magnitude of the interplay effect in a scanned beam delivery is the "rescanning" technique, first proposed by Phillips et al. more than 20 yr ago. 88 This method is based on the statistical averaging of positional errors. Dose errors are smoothed out by irradiating the target volume multiple times. Several groups have introduced a range of rescanning techniques. 72, [88] [89] [90] [91] [92] [93] In terms of rescanning path, there are two major flavors: layered and volumetric rescanning. Layered rescanning repetitively irradiates each scanning iso-energy layer. Upon finishing rescanning of one iso-energy layer, the beam energy is changed to do rescanning in the next adjacent iso-energy layer. This process is repeated until all iso-energy layers are irradiated. The number of beam energy changes is the same as the number of iso-energy layers and is independent of the number of rescannings. In contrast, volumetric rescanning irradiates all beam spots from the most distal to the most proximal iso-energy layers multiple times. The number of beam energy changes required is the number of iso-energy layers multiplied by the number of rescannings. If the time to change the energy to deliver the next layer is very short, a volumetric rescanning is possible; however, care has to be taken with regard to synchronization effects. 90, 94 The choice of rescanning method and the magnitude of minimization of the interplay effect are strongly dependent on the specific characteristics of the irradiation system (scanning speed, beam energy change time, beam spot size, number of beam fields etc.). Therefore, it has been shown that it is especially beneficial to combine several motion mitigation techniques such as rescanning and gating 91, 93 or tracking (described in the next section) and gating. 95 Zhang et al. showed that tumor motion mitigation for targets moving less than 5 mm can safely be achieved with a combination of gating and five times rescanning. 93 Several researchers have therefore reported optimum rescanning parameters to improve dose conformation, however, the rescanning techniques described above are applied to a moving target, and do not consider time (= respiratory cycle). The recently introduced respiratory-correlated rescanning technique involves both layered and volumetric rescanning to avoid synchronization issues. 89, 92 The respiratory-correlated layered rescanning completed the irradiation of an iso-energy layer within the gating window. While the respiratory-correlated volumetric rescanning irradiated whole volume at the beginning of the gating window and, if gating is applied, completed the rescanning at the end of the gating window (Fig. 15) . Even with ungated treatment, dose conformation to the moving target could be improved by increasing the number of rescannings to four or more times (Fig. 16) . 91 The respiratorycorrelated layered rescanning technique was integrated into the Toshiba particle beam treatment system. To achieve respiratory-correlated rescanning, the dose rate for respective isoenergy layers is calculated from the gating window time and/ or patient respiratory cycle before irradiation. This means that the scanning irradiation pattern cannot be changed during treatment in the current system. In practical treatment situations, however, patient respiratory patterns (respiratory cycle and amplitude) can vary during treatment. Therefore, when the respiratory cycle is shorter than that at treatment planning, all beam spots at a certain iso-energy layer are not completed within a single gating window, and the remaining beam spots are irradiated at the start of the next gating window. In contrast, when the respiratory cycle is longer than that in treatment planning, all beam spots are irradiated completely before the end of the gating window. This situation degrades the probability density function between the moving target and beam spot positions. If the respiratory cycle is varied by approximately AE3 s from that at treatment planning, respiratory-correlated rescanning four or more times will prevent dose degradation within the moving target. 96 Another merit of respiratory-correlated rescanning is its improved dose conformity with four or more rescannings. Multiple rescannings with respiratory-correlation (>10 times, depending on treatment machine) is not good for the scanning magnet system due to its fast scanning power switching. Moreover, if beam spot transition is done without turning off the beam (raster-scanning), unnecessary doses between beam spots might accumulate with an increased number of rescans.
3.B. Target tracking with active range control
Among all possible motion mitigation approaches, beam tracking has been considered as the optimal technique, since it should not lead to excessive treatment prolongation or target volume expansions. 97 In conventional radiotherapy, tumor tracking is performed using either a robotic radio-surgery system, 98 dynamic multileaf collimators, 99, 100 or couch movements. 101 The most straightforward approach to tumor tracking with particle beam therapy could be provided by PBS particle beams. It is relatively straight forward to track motion with a particle beams by modifying the scanning pattern to directly follow the tumor motion. 102 The Bragg Peak position can be adapted to the moving tumor position in three The first rescanning delivery of the m-th iso-energy layer starts from the upper right spot to the lower right spot during the first third of the gating window; the second rescanning returned along the reversed trajectory of the first scanning during the middle third of the gating window; and the third rescanning is delivered along the original path during the last third of the gating window. After completing the rescanning of the m-th iso-energy layer, next iso-energy layer (m + 1th) are delivered in the same manner. Lower panel: In this example, four gating windows were required to achieve 3 times respiratory-correlated volumetric rescanning. The first volumetric rescanning is performed from t1 to t4, the second rescanning is started immediately from t4 to t8, and third rescanning is done at t10. With permission 93. dimensions, namely, x-and y-position in the lateral plane as well as particle beam energy. Tracking might seem to completely resolve the motion challenge for scanned particle beams. However, Van de Water and colleagues concluded that beam tracking for protons is very sensitive to position uncertainties. 103 Furthermore, beam tracking can only recover the planned dose delivery to areas beside the actual Bragg Peak position for pure translational motion. Motions containing e.g., rotational or deformational components result in changes of the overall dose deposition even though beam tracking is used. 102, 104 Tracking with particle beams requires not only lateral beam adjustments, but also energy adaption for compensation of range changes resulting from motion induced density variations. 97 Thus, tracking can only be effective if real-time 3D information on the tumor location is known at all times. Motion monitoring capabilities during radiotherapy are more advanced in photon therapy than in particle therapy. 105 However, image guidance in particle therapy is slowly beginning to catch up with conventional therapy. In-room imaging in form of in-room CT and CBCT is becoming available. 106 Cone-beam CT based proton dose calculations have been investigated 107 and the utilization of 4D-CBCT data for dose calculation will be a future area of research. However, current imaging capabilities still do not provide real time 4D information. So far clinical implementation of tracking would rely on a smart combination of preacquired data and online surrogate information. In work by Zhang et al. an efficient model-based motion reconstruction method using preacquired 4DMRI data, which allows for online prediction of 3D deformable motion from sparse surrogate motions tracked via an on-board, Beams'Eye View (BEV) X-ray imaging system was successfully developed. 108 In the future a combined MRproton machine (see also Section 2.D) could provide real time 4D information.
At the Gesellschaft f€ ur Schwerionenforschung, an experimental system for motion tracking has been developed and integrated in the therapy control system. As seen in Fig. 17 , it could be shown that by applying tracking a dose distribution delivered to a moving phantom could be preserved and that target conformity could be maintained. 102 A dose simulation study for a tracked delivery with a scanned proton beam to a phantom geometry was performed by van de Water et al. 103 A clinical simulation of online image guided tumor tracking with scanned proton beams was performed by Zhang et al. 109 It was shown that interplay effects could be significantly reduced applying tracking. A dosimetric comparison revealed that for liver tumor indications, only a small benefit of deformable 3D tracking w.r.t conventional 2D tracking can be seen, and these gains are mainly evident for the large motion cases. Moreover, as highlighted in Fig. 18 , it has also been shown that beam tracking alone cannot fully mitigate all motion effects, but that combining tracking with rescanning (retracking) could provide an approach which combines the best aspects of tracking (better dose conformation) and rescanning (washout of interplay effects). 109 For now, tracking in particle therapy remains a research topic and will take several years before being implemented clinically.
CONCLUSION
In this review, we have given a summary of available motion monitoring solutions for particle radiotherapy and have described motion mitigation techniques to be used during particle therapy delivery. As particle beams are very sensitive to geometrical changes and density changes along the beam axis, 3D image information is required for treatment validation and adaptation. 3D iso-centric imaging possibilities at particle facilities are still rare and need further development.
Tumor motion presents a special challenge for the delivery of particle therapy treatments. In the literature several motion mitigation approaches such as treating during breath-hold, rescanning, gating or tracking have been suggested. It appears to be most beneficial to combine several motion mitigation techniques in order to guaranty a safe and robust treatment of moving targets with particle beams.
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